Versatope Therapeutics is a biotechnology company based in Lowell, MA, specializing in the development of innovative vaccines and targeted RNA therapeutics for infectious diseases and cancer. Their transformative biotechnology platform utilizes Recombinant Extracellular Transport Vesicles (RET-V's) to deliver cross-strain immunity, confer long-term protection, and enable rapid synthesis and distribution of vaccines.
With a focus on molecular engineering and bioinformatics, Versatope designs multi-strain vaccines using probiotic vesicles, providing a competitive advantage over single strain vaccines. Their cutting-edge approach aims to revolutionize immunotherapy by delivering therapeutic RNA directly into cancer cells and protecting against emerging strains of infectious diseases, including Influenza.
Generated from the website